Literature DB >> 9454978

Neurocysticercosis in children. Clinical experience in 122 patients.

M Ruiz-García1, A González-Astiazarán, F Rueda-Franco.   

Abstract

Cysticercosis is the most frequent parasitic disease of the central nervous system in the world and is endemic in such developing countries as Mexico. There is insufficient information about neurocysticercosis in children. The purpose of this study was to collect information on the main social factors associated with neurocysticercosis, the clinical picture, diagnosis and treatment, and the final outcome in 122 Mexican children. The ages of the patients ranged from 14 months to 17 years, with a mean of 8 years; 51 male (41.8%) and 71 female (51.8%) patients were seen; half of these patients (61) lived in well-urbanized areas; the parents of 77 families (57.3%) had only an elementary school grade average, and 46 (37.7%) lived in close proximity to animals. The most common features were seizures, intracranial hypertension and learning disabilities. The diagnosis of neurocysticercosis was supported by computed tomography or magnetic resonance imaging studies and cerebrospinal fluid analysis. The treatment was varied, with anti-convulsives, steroids, and albendazole, and only 8 patients underwent ventriculo-peritoneal shunts for hydrocephalus. The follow-up ranged from 6 months to 5 years; 90 patients became asymptomatic; 6 developed refractory epilepsy; 14, learning disabilities; and 10, a chronic type of the disease with repeated episodes of intracranial hypertension; 2 died because of chronic arachnoiditis.

Entities:  

Mesh:

Year:  1997        PMID: 9454978     DOI: 10.1007/s003810050152

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  8 in total

1.  Prevalence of neurocysticercosis among people with epilepsy in rural areas of Burkina Faso.

Authors:  Athanase Millogo; Pascal Nitiéma; Hélène Carabin; Marie Paule Boncoeur-Martel; Vedantam Rajshekhar; Zékiba Tarnagda; Nicolas Praet; Pierre Dorny; Linda Cowan; Rasmané Ganaba; Sennen Hounton; Pierre-Marie Preux; Rabiou Cissé
Journal:  Epilepsia       Date:  2012-11-13       Impact factor: 5.864

2.  Psychiatric manifestations of neurocysticercosis in paediatric patients.

Authors:  Laura de Anta Tejado; Kazuhiro Tajima Pozo; Camila Bayón Palomino; José Luis de Dios de Vega
Journal:  BMJ Case Rep       Date:  2012-08-14

Review 3.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

4.  Endoscopic excision of intraventricular neurocysticercosis in children: a series of six cases and review.

Authors:  Ashish Suri; Rohit Kumar Goel; Faiz Uddin Ahmad; Ananth Kesav Vellimana; Bhawani Shankar Sharma; Ashok Kumar Mahapatra
Journal:  Childs Nerv Syst       Date:  2007-11-10       Impact factor: 1.475

5.  Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

Review 6.  Clinical manifestations associated with neurocysticercosis: a systematic review.

Authors:  Hélène Carabin; Patrick Cyaga Ndimubanzi; Christine M Budke; Hai Nguyen; Yingjun Qian; Linda Demetry Cowan; Julie Ann Stoner; Elizabeth Rainwater; Mary Dickey
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

7.  Neurocysticercosis in Children with Seizures: A Cross-Sectional Study.

Authors:  Murli Manohar Gupta; Nagendra Chaudhary; Santosh Pathak; Nikhil Agrawal; Jaydev Yadav; Sandeep Shrestha; Om Prakash Kurmi; Baldev Bhatia; Kailash Nath Agarwal
Journal:  Int J Pediatr       Date:  2018-05-21

8.  Mathematical model of the life cycle of taenia-cysticercosis: transmission dynamics and chemotherapy (Part 1).

Authors:  Marco V José; Juan R Bobadilla; Norma Y Sánchez-Torres; Juan Pedro Laclette
Journal:  Theor Biol Med Model       Date:  2018-11-19       Impact factor: 2.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.